199 related articles for article (PubMed ID: 12847234)
1. IL-15-mediated induction of LFA-1 is a late step required for cytotoxic differentiation of human NK cells from CD34+Lin- bone marrow cells.
Barao I; Hudig D; Ascensao JL
J Immunol; 2003 Jul; 171(2):683-90. PubMed ID: 12847234
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
Yu Y; Hagihara M; Ando K; Gansuvd B; Matsuzawa H; Tsuchiya T; Ueda Y; Inoue H; Hotta T; Kato S
J Immunol; 2001 Feb; 166(3):1590-600. PubMed ID: 11160200
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
[TBL] [Abstract][Full Text] [Related]
4. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction via phosphorylated adhesion molecule, LFA-1 beta (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells.
Umehara H; Takashima A; Minami Y; Bloom ET
Int Immunol; 1993 Jan; 5(1):19-27. PubMed ID: 8095153
[TBL] [Abstract][Full Text] [Related]
6. Identification of a NCR+/NKG2D+/LFA-1(low)/CD94(-) immature human NK cell subset.
Zamai L; Galeotti L; Del Zotto G; Canonico B; Mirandola P; Papa S
Cytometry A; 2009 Nov; 75(11):893-901. PubMed ID: 19743412
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic functions and susceptibility to apoptosis of human CD56(bright) NK cells differentiated in vitro from CD34⁺ hematopoietic progenitors.
Zamai L; Del Zotto G; Buccella F; Galeotti L; Canonico B; Luchetti F; Papa S
Cytometry A; 2012 Apr; 81(4):294-302. PubMed ID: 22319021
[TBL] [Abstract][Full Text] [Related]
8. Flt3 ligand promotes the generation of a distinct CD34(+) human natural killer cell progenitor that responds to interleukin-15.
Yu H; Fehniger TA; Fuchshuber P; Thiel KS; Vivier E; Carson WE; Caligiuri MA
Blood; 1998 Nov; 92(10):3647-57. PubMed ID: 9808558
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity.
Matsumoto G; Nghiem MP; Nozaki N; Schmits R; Penninger JM
J Immunol; 1998 Jun; 160(12):5781-9. PubMed ID: 9637488
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
11. Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity.
Matsumoto G; Omi Y; Lee U; Nishimura T; Shindo J; Penninger JM
Eur J Immunol; 2000 Dec; 30(12):3723-31. PubMed ID: 11169416
[TBL] [Abstract][Full Text] [Related]
12. Generation of human natural killer cells from immature progenitors does not require marrow stromal cells.
Silva MR; Hoffman R; Srour EF; Ascensao JL
Blood; 1994 Aug; 84(3):841-6. PubMed ID: 7519079
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.
Mrózek E; Anderson P; Caligiuri MA
Blood; 1996 Apr; 87(7):2632-40. PubMed ID: 8639878
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.
Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; De Coene C; Selz F; Le Deist F; Fischer A
Blood; 1996 Nov; 88(10):3901-9. PubMed ID: 8916956
[TBL] [Abstract][Full Text] [Related]
16. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
Lauwerys BR; Garot N; Renauld JC; Houssiau FA
J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
[TBL] [Abstract][Full Text] [Related]
17. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
[TBL] [Abstract][Full Text] [Related]
18. LFA-1 contributes an early signal for NK cell cytotoxicity.
Barber DF; Faure M; Long EO
J Immunol; 2004 Sep; 173(6):3653-9. PubMed ID: 15356110
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic activation of the cytotoxic phenotype during human NK cell development.
Meade JL; Wilson EB; Holmes TD; de Wynter EA; Brett P; Straszynski L; Ballard PA; Trapani JA; McDermott MF; Cook GP
J Immunol; 2009 Jul; 183(2):803-13. PubMed ID: 19570824
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-15-activated natural killer cells kill autologous osteoclasts via LFA-1, DNAM-1 and TRAIL, and inhibit osteoclast-mediated bone erosion in vitro.
Feng S; Madsen SH; Viller NN; Neutzsky-Wulff AV; Geisler C; Karlsson L; Söderström K
Immunology; 2015 Jul; 145(3):367-79. PubMed ID: 25684021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
